More than 30% of genes in higher eukaryotes are regulated by promoter-proximal pausing 25 of RNA polymerase II (Pol II). Phosphorylation of Pol II-CTD by positive transcription 26 elongation factor (P-TEFb) is a necessary precursor event that enables productive 27 transcription elongation. The exact mechanism on how the sequestered P-TEFb is released 28 from the 7SK snRNP complex and recruited to Pol II-CTD remains unknown. In this 29 report, we reveal methylphosphate capping enzyme (MePCE), a core component of the 30 7SK snRNP complex, as the cognate substrate for Jumonji domain-containing 6 (JMJD6)'s 31 novel proteolytic function. Our evidences consist of a crystal structure of JMJD6 bound to 32 methyl-arginine, enzymatic assays of JMJD6 cleaving MePCE in vivo and in vitro, binding 33 assays, and downstream effects of Jmjd6 knockout and overexpression on Pol II-CTD 34 phosphorylation. We propose that JMJD6 assists bromodomain containing 4 (BRD4) to 35 recruit P-TEFb to Pol II-CTD by disrupting the 7SK snRNP complex. 36
Introduction 37
Mechanisms of transcription regulation in bacteria are very well established; 38 transcription factors bind to specific DNA to recruit RNA Polymerases (RNAP) to carry 39 out transcription (Ptashne and Gann 1997, Zhang, Campbell et al. 1999 ). In eukaryotes, Konuma, Yu et al. 2017 ). Incidentally, we found that JMJD6 70 nonspecifically binds to single stranded RNA with high affinity (~40nM) (Hong, Zang et 71 al. 2010) . We propose that JMJD6 may be recruited by both BRD4 and newly transcribed 72
RNAs from Pol II to help BRD4 recruit P-TEFb, acting analogously to that of TAT protein 73 associating with both P-TEFb and TAR. 74 JMJD6 is one of the most controversial proteins in biology (Vangimalla, Ganesan 75 et al. 2017) . It was first cloned as phosphatidylserine (PS) receptor (Fadok, Bratton et al. 76 2000) , but was corrected as a nucleus expressed protein unrelated to PS ( , we re-interrogated proposed substrates using stringent and unified 99 criteria. As we reported previously, JMJD6 binds with high binding affinity (~40nM) to 100 single stranded RNA (ssRNA) without sequence specificity (Hong, Zang et al. 2010) . 101
However, truncation analysis showed that JMJD6 barely binds to ssRNA without the C- (1-343) and monomethyl arginine (MM-Arg). Surface charges were generated using PyMOL (Action > generate > vacuum electrostatics > protein contact potential) (https://pymol.org/2/). Red represents negatively-charged surface, Gray represents neutralcharged surface, and Blue represents positively-charged surface. b. Omit map 2Fo-Fc electron density of MM-Arg. c. Magnified view of MM-Arg in the catalytic center of JMJD6 d. Coordination of elements at catalytic center.
JMJD6 without C-terminal motif (1-343) were soaked with a monomethylarginine 114 derivative. Interestingly, four out of eight JMJD6 molecules within an asymmetric unit 115 bound to monomethylarginine, which coordinates with Fe2+ and alpha-KG in the catalytic 116 center similar to that of JMJD5 and methylarginines ( Fig. 1, Fig.S1, Fig. S2 , Fig. S3 , Table  117 S1). However, the methylated sidechain of arginine is located in a more open catalytic 118 space containing negatively charged residues, compared to that of JMJD5, indicating that 119 the pocket could hold more than one sidechain ( Fig. 1A) . This may suggest a novel 120 substrate recognition mode, which is different from that of JMJD5 (Liu, Wang et al. 2018) . 121
Nevertheless, the complex structure shows several key evidences. First, JMJD6 does bind 122 to substrates with methylarginine or possibly methyllysine or both arginine and lysine with 123 and without methylation ( Fig. 1B, 1C ). Second, the methyl group is far away from either 124 the divalent ion or alpha-KG, suggesting JMJD6 may not act as lysine or arginine 125 demethylases to remove methyl groups on the sidechain of either lysine or arginine. Third, 126 peptides or proteins could be cognate substrates instead of RNA or DNA, which do not 127 contain any positive charge with or without methylation. Fourth, the catalytic center 128 contains analogous residues present in JMJD5 and JMJD7, suggesting a similar novel 129 catalytic mechanism as those of JMJD5 and JMJD7 through an imidic acid as proton Furthermore, a comprehensive protein composition analysis using mass spectrometry 134 (Table S2 ) of all purified recombinant JMJD6 samples used in the following experiments 135 could not detect any protease contaminants. 136
JMJD6 cleaves MePCE 137
Since JMJD5 and JMJD7 make cleavage on histone tails (Liu, Wang et al. 2017 ), 138
we asked whether JMJD6 also recognizes histone tails. Interestingly, JMJD6 does in fact 139 have activities on bulk histone in vitro (Fig. S4A ). This result may explain why two groups 140 found that JMJD6 could reduce methylarginine containing histone tails in in vitro assays suggesting that JMJD6 is a global master transcriptional regulator controlling expression 163 of a large group of genes including components from the 7SK snRNP complex. However, 164 our RNA-Seq data do not support direct transcriptional downregulation of 7SK snRNP 165 complex members at mRNA level ( Table S3 ). All of them, including MePCE, LARP7, and 166 HEXIM1 have similar mRNA levels with or without Jmjd6. At the moment, the cause of 167 this downregulation of proteins level of these components from 7SK snRNP remains 168 unresolved and is beyond the scope of this report. However, when we introduce back 169 JMJD6 via overexpression into MEF cells lacking Jmjd6, protein levels of LARP7 and 170 HEXIM1 are rescued, whereas MePCE is not ( Fig. 2A ). To account for this disappearance 171 of MePCE, we hypothesized that overexpression of JMJD6 may directly target MEPCE 172 for degradation. To confirm this hypothesis, we respectively overexpressed full-length 173
MePCE in wild-type MEF, Jmjd6 knockout MEF, wild-type JMJD6 overexpression in 174 Based on the binding of JMJD6 to methylated arginine we obtained from the 198 complex crystal structure, we reasoned that arginine residues within approximately the first 199 200 residues of MePCE could contain the recognition site. Several peptide fragments 200 including residues from 81 to 160, residues 154 to 184, and residues 187 to 244 were 201 synthesized. Peptides of 81-160 and 187-244 did not show any cleavage when incubated 202 with JMJD6. Peptides of 154-184 showed cleavage activity, but at levels of <1% compared 203 to peptide input. We attributed this low activity as a matter of insolubility and dimerization 204 via C177 oxidation. To overcome this obstacle, a shorter peptide from residue 161 to 179 205 containing C177S was synthesized and subjected to enzymatic reaction under JMJD6. This 206 peptide also contains symmetric dimethylation on R171, given that our binding data, 207 described in the next section, suggests that this particular modification yields the highest 208 binding affinity (Fig. 3C ). In line with our expectations, dominant peaks corresponding to 209 the cleaved MePCE peptide products were detected by mass spectrometry, but not in either 210 peptide alone or with an inactive mutant version of JMJD6 ( Fig. 2E) . 211
212

JMJD6 specifically recognizes methylarginine within MEPCE 213
To determine the binding affinity between JMJD6 and the newly discerned MePCE 214 proteolysis site, Microscale Thermophoresis (MST) assay was performed using catalytic 215 core of JMJD6 (1-343) titrated with the MePCE (154-184) peptide exhibiting: no 216 modification ( Fig. 3A ), R170-me2s ( Fig. 3B ), or R171-me2s (Fig. 3C ). The highest binding 217 affinity was exhibited by the MePCE (154-184)-R171-me2s peptide with Kd = 159 ± 77 218 nM, followed by the peptide containing no modification with Kd = 471 ± 292 nM, and 219 lastly the peptide with R170-me2s with Kd = 568 ± 316 nM. Fluorescence polarization 220 respectively fell within the margin of error (Fig. S5A, A5B, S5C) . These data suggest that 223 methylation on R171 enhances binding nearly 3-fold compared to no modification, 224
whereas methylation on R170 diminishes binding marginally. Whether or not these 225 particular methylations occur in vivo is yet to be explored. Interestingly, the YASARA 226 groups have previously purported, the identical MST assay was performed using peptides 235 derived from Histone 3 (1-21) containing no modification (H3) (Fig. 3D) , Histone 3 (1-236 16)-R2-me2s (H3R2me2s) (Fig. 3E ), and C-peptide (57-87) as a negative control (Fig. 3F) . 237
For the Histone 3 peptides, low binding affinity was exhibited with Kd = 77 ± 34 µM for 238 H3 peptide and Kd = 98 ± 14 µM for H3R2me2s peptide. No meaningful binding was 239 observed for the C-peptide (Fig. 3F) . not only that JMJD6's cleavage of MePCE is essential for P-TEFb to be released from the 257 7SK snRNP complex and ultimately the phosphorylation of Ser2-CTD of Pol II, but also 258 further cross-confirms that a species of Ser2p-CTD of Pol II is indeed generated by CDK9. 259
The content of Ser2p-CTD of Pol II is recovered when JMJD6 is re-expressed ( Fig. 4A) , 260
suggesting the direct relation of JMJD6 and phosphorylation of Ser2-CTD of Pol II in vivo. 261
When these results are aggregated with previously published reports, whereby (1) JMJD6 262 exhibits strong binding affinity to nonspecific ssRNA as we previously reported (Hong, The association between BRD4 and JMJD6 allows BRD4 to bring P-TEFb (CDK9) to close 269 proximity of CTD of Pol II, allowing for Ser2-CTD phosphorylation (Fig. 4B) . 270
Remarkably, this recruitment of P-TEFb by JMJD6, with the assistance of BRD4, is similar 271 to that of TAT protein hijacking P-TEFb complex after associating with TAR transcript to 272 trigger the expression of HIV retroviral genome ( Fig. 4C) Based on our current discoveries, we may derive a novel transcription regulation 326 pathway for genes regulated by promoter-proximate pausing Pol II. First, upon stimulation 327 of cells, signals will reach specific transcription factors through signal transduction 328 pathways. With modification or with the help of other partner molecules, these 329 transcription factors bind to enhancers close to the paused Pol II. These transcription 330 factors will recruit P300/CBP with the help of H3K4(me1) at enhancer regions, which in 331 turn acetylates H3 and/or H4 on the same nucleosome bound by P300/CBP through 332 association with H3K4(me1) to generate acetylated H3 and/or H4 (Fig. 5A ). Next, BRD4 333 is recruited to acetylated H3 and/or H4, and in turn engages with JMJD6 and the initiated 334
Pol II complex. JMJD6 specifically cleaves MePCE of the 7SK snRNP complex so as to 335 release the P-TEFb complex containing CDK9 (Fig. 5B ). Finally, JMJD6 and BRD4 brings 336 P-TEFb to close proximity of CTD of Pol II. P-TEFb (CDK9) then phosphorylates Ser2-337 CTD of Pol II (Fig. 5C) . 338 
Materials and Methods 340
Protein expression and purification. The cDNA corresponding to gene of wild-type 341 JMJD6 (1-343), inactive mutant JMJD6 (1-343) H187A/D189A/H273A/K204A/N287A, 342 HEXIM2, and LARP7 was cloned into a pET28a vector containing an N-terminal His 6 tag. 343
The DNA corresponding to gene of JMJD6 (1-403) wild-type was cloned into a pGEX 344 Table S1 . Crystallographic statistcs of complex structure of JMJD6 and a methylated arginine. Table S2 . Protein Composition Analysis via Mass Spectrometry. Bacteria expressed and purified JMJD6 are subjected to mass spectrum analysis, all potential contaminated trace protein candidates are listed. No known protease candidate is identified from the list. Table S3 . Total RNA-seq reads of wild-type MEF, JMJD6 knockout MEF, and JMJD6 overexpressed in JMJD6 KO background MEF.
